Prognostic Factors, Incidence and Management for Acute Variceal Bleeding in the Liver Transplantation Era


Background: Gastroesophageal varices are the most common and clinically important part of the portosys-temic collaterals due to their tendency to rupture and cause massive gastrointestinal bleeding. Objective The aim of this work was to evaluate retrospectively the incidence and the factors of prediction for the treatment of bleeding by gastroesophageal varices in the patients attended in the Emergency Room of the Hospital State University of Campinas (Brazil) from the last ten years. Methods: The method used here consisted of a descriptive and retrospective study carried out from the analyses of the medical records of 769 patients with upper gastrointestinal bleeding of which 220 were admitted because of upper gastrointestinal bleeding caused by gastroesophageal varices during this same period. Results: The results showed that the gastroe-sophageal varices appeared in 28.6% of the patients and they were the second most common cause of upper gastrointestinal bleeding. While evaluating factors such as age, sex and the common individual records, it was proved that this disease occurs mainly among people between the third and the fifth decade of life, with the great majority of cases occurring in the fourth decade (29.2%), of which 76.8% were male. There was an association of hematemesis and melena in the admission of 57.7% of the patients and even ascites was a common diagnosis in 48.2% of them. Most of these patients (40%) were classified as Child class B at admis-sion. The early endoscopic exam was used for 96.8% of them and showed the presence of F3 varices in 38.5%, CB varices in 25.1% and RCS varices in 12.6%. Most of these varices (41.5%) were situated in the distal third of the esophagus. The most used pharmacological treatment was based on octreotide in 45.9% of the patients. They received 0.05 mg of intravenous octreotide and a maintenance dose of 1 mg per day in 98.6% of the cases, with efficacy in 74.2% of the patients. The tamponade with Sengstaken-Blakemore tube was applied in 30.5% of the patients, but it was observed that 69.7% of them did not present any consider-able progress and this situation led to their death. The endoscopic treatment was performed in 41.8% of the patients with efficacy in 81.5% of them. The sclerotherapy was used for 60.9% of the studied cases with Ethamolin® being the most used for sclerosing. Emergency surgery was used in just 8.6% of the patients studied and it controlled the bleeding in 78.9% of the cases. Conclusion: We concluded that gastroesophag-eal bleeding was an important cause of upper gastrointestinal hemorrhage, even in the liver transplantation era. Factors of prediction for this bleeding were the endoscopic classification, the presence of ascites and the degree of liver failure, according to the Child-Pugh classification.

Share and Cite:

É. Silva, I. Boin, E. Filho, P. Rodrgiues and B. Silva, "Prognostic Factors, Incidence and Management for Acute Variceal Bleeding in the Liver Transplantation Era," Surgical Science, Vol. 2 No. 4, 2011, pp. 198-203. doi: 10.4236/ss.2011.24044.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] N.A. Andreollo, E.R.Rodas, M.C.Y.B. Braile, M.N.J. Faria, A. Yamanaka, N.A Brandalise. Diagnóstico endoscópico da hemorragia digestiva alta: Estudo retrospectivo em hospital universitário. Arq Bras Med Vol.63, No. 1, 1989, pp. 43-47.
[2] M.S. Barsoum, F.I. Bolous, A.A. El-Rooby. Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg Vol. 69, No.2, 1982, pp. 76-78.
[3] L.S. Leonardi, I.F.S.F. Boin, N.A. Brandalise, N.A. Andreollo, F. Callejas Neto, J.C. Pareja. Results of the azigo-portal disconnection and splenectomy associated with sclerotherapy in schistosomiasis. ABCD - Arq Bras Cir Dig Vol.3, No.4, 1988, pp. 99-103.
[4] Boin IFSF, Sevá-Pereira G, Bittencourt D, Leonardi LS. Results of Surgical Treatment of portal hypertension. In: Gonzalez, EM, Paschoal, MH – 3rd World Congress Of IHPBA – Book Proceedings. Madri, 1999. pp. 94-96.
[5] J. Bosch, G. D’amico, A. Luca, J.C. García-Pagán, F. Feu, A. Escorsell. Drug therapy for variceal haemorrhage. In: Bosch J et al., editores, Portal hypertension pathophysiology and treatment. London. Blackwell Scientific Publications, 1994. pp. 108-123.
[6] P. Dave, J. Romeu, J.Messer. Upper gastrointestinal bleeding in patients with portal hypertension: A reappraisal. J Clin Gastrenterol Vol.78, No. 11, 1983, pp. 113-115.
[7] O. Duhamel, J.P. Carle, J.P. Daures, A. Boyer, J. Gislon, B. Nalet et al. Primary prevention of digestive hemorrhage, caused by rupture of esophageal varices, by endoscopic sclerotherapy in patients with liver cirrhosis. Multicenter Randomizes Controlled Study. Gastroenterol Clin Biol Vol. 18, No. 1, 1994, pp. 57-62.
[8] M.A. Fallah MA, C. Praskash, S. Edmundowicz. Acute gastrointestinal bleeding. Gastroenterol Clin N Am Vol. 84, No. 5, 2000, pp. 1183-1208.
[9] J.S.Goff. Gastroesophageal varices: pathogenesis and therapy of acute bleeding. Gastroenterol Clin N Am Vol. 22, No. 4, pp. 779-800.
[10] N.D. Grace. A hepatologists view of variceal bleeding. Am J Surg Vol. 160, No. 1. 1990, pp. 26-31.
[11] D.Y. Graham, J.L. Smith. The course of patients after variceal hemorrhage. Gastroenterology Vol. 80, No. 4, 1981, pp. 800-809.
[12] R.J. Groszmann, J. Bosch, N.D. Grace, H.O.Conn, G. Garcia-Tsao, M. Navasa et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology Vol. 99, No. 5, 1990, pp. 1401-1407.
[13] V.A. Luketic, A.J. Sanyal. Esophageal varices I. Clinical presentation, medical therapy, and endoscopic therapy. Gastroenterol Clin N Am Vol. 29, No.2, 2000, pp. 337- 385.
[14] D.S. Matloff. Treatment of acute variceal bleeding. Gastroenterol Clin N Am Vol. 21, No. 1, 1992, pp. 103- 118.
[15] M.A. Mercado, H. Orozco, F.F. Ramírez-Cisneros, C.A. Hinojosa, J.J. Plata, J. Alvarez-Tostado. Diminished morbidity and mortality in portal hypertension surgery: Relocation in the therapeutic armamenterium. J Gastroint Surg Vol. 5, No.5, 2001, pp. 499-502.
[16] M.J. Orloff, M.S. Orloff, B. Girard, S.L.Orloff. When is liver transplant Indicated in cirrhosis with bleeding varices? Transplant Proc Vol.33, No. 1-2, 2001, pp. 1366.
[17] L. Pagliaro, G. D’amico, L.Pasta, F. Politi, G. Vizzini, M. Traina et al. - Portal Hipertension in Cirrhosis: Natural History - In: Bosch J, Groszmann RJ - Portal hypertension pathophysiology and treatment. London. Blackwell Scientific Publications, 1994. pp. 72-92.
[18] J. Panes, J. Teres, J. Bosch. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices: Results in 151 consecutive episodes. Dig Dis Sci Vo. 33, No. 4, 1988, pp. 454-459.
[19] J.C. Pareja, L.S. Leonardi. Hemorragia digestiva alta por varizes esofagogástricas. In Leonardi LS – Cirurgia de urgência do aparelho digestivo. Rio de Janeiro, Medsi, 1986. pp. 111-117.
[20] H.C. Pinto, A. Abrantes, A.V. Esteves. Long term prognosis of the liver and upper gastrintestinal bleeding. Am J Gastrenterol Vol. 84, No. 10, 1989, pp. 1239-1243.
[21] D. Prandi, B. Rueff, J. Roche-Sicot. Life-threatening hemorrhage of the digestive tract in cirrhotic patients. Am J Surg 1976, Vol. 131, No. 2, 204-209.
[22] R.N.H. Pugh, I.M. Murray-Lyon, J.L. Dawson. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg Vol. 60, No. 8, 1973, pp. 646-649.
[23] S. Raia, L.C. Silva, L.C.C. Gayotto, S.C. Foster, J. Fukushima, E. Strauss. Portal hypertensionin schistosomiasis. A long term follow-up of a randomized trial comparing three types of surgery. Hepatology Vol. 20, No. 2, 1994, pp. 398-403.
[24] L.F. Rikkers. Bleeding esophageal varices. Clin Cir Am Norte Vol. 67, No. 3, 1987, pp. 487-488.
[25] L.F. Rikkers. Definitive therapy for variceal bleeding: A personal view. Am J Surg Vol 160, No. 1, 1990, pp. 80- 85.
[26] D.L. Jacobs, L.F. Rikkers. Indications and results of shunt operations in the treatment of patients with recurrent variceal hemorrhage. Hepatogastroenterology Vol. 37, No. 6, 1990, pp. 571-574.
[27] L.F. Rikkers LF, G. Jin. Variceal hemorrhage: surgical therapy. Gastroenterol Clin N Am Vol. 22, No. 4, 1993, pp. 821-842.
[28] H. Yoshida, Y. Mamada, N. Taniai, S. Mineta, Y. Kawano, Y. Mizuguchi et al. Shunting and nonshunting procedures for the treatment of esophageal varices in patients with idiopathic portal hypertension. Hepatogastroenterology Vol. 57, No. 102-103, 2010, pp. 1279-1284.
[29] J. L. Smith, D.Y. Graham. Variceal hemorrhage: A critical evaluation of survival analysis. Gastroenterology Vol. 82, No. 5 Pt 1, 1982, pp. 968-973.
[30] W. Andraus, R. Pinheiro, L.B. Haddad, P. Herman, L.A. D’Albuquerque. The best approach for splenectomy in portal hypertension. Surgery Apr 15, 2011. [Epub ahead of print].
[31] Strauss E. Band ligation, sclerotherapy, both or...brains? Am J Gastroenterol Vol. 92, No. 6, 1997, pp.920-923.
[32] L. Li, C. Yu, Y. Li. Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol Vol 25, No. 3, 2011, pp. 147-155.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.